4. Generic Version of BPH Drug, Tadalafil, Being Readied for Testing in Clinical Trials
MS Rehab Systems, Inc., reported its generic drug subsidiary, BioPharmcor BV, is in the final development and preclinical testing stages for the generic version of tadalafil, a potential first-line treatment for men with erectile dysfunction (ED) and benign prostatic hyperplasia (BPH).
The drug will next be evaluated in clinical trials to test its bioequivalence to Cialis, the brand name for tadalafil and an approved treatment for these conditions, the company announced in a press release. Tadalafil works by relaxing the muscles in the walls of blood vessels to increase blood flow.
